Government signs a zero-dollar deal for future drug purchases

A government agency signed a contract with Neurocrine Biosciences, Inc. for pharmaceutical products. The contract has a zero dollar value and starts in 2026. This means the government can place orders for drugs from this company without needing a new bidding process each time.

Government agencies often set up these kinds of agreements for future purchases. This contract does not mean new drugs are coming. It also does not mean spending will increase. It just makes it easier to buy existing products from this company later.